Source: https://sites.dartmouth.edu/pdt/proceedings/
Timestamp: 2019-04-24 07:13:46+00:00

Document:
E. V. Maytin, S. Anand, “Combination photodynamic therapy using 5-fluorouracil and aminolevulinate enhances tumor-selective production of protoporphyrin IX and improves treatment efficacy of squamous skin cancers and precancers” Proc. SPIE 9694, 96940E (2016); doi: 10.1117/12.2218138.
S. Anand, Erik Thomas, Tayyaba Hasan, Edward V. Maytin, “Vitamin D for combination photodynamic therapy of skin cancer in individuals with vitamin D deficiency: Insights from a preclinical study in a mouse model of squamous cell carcinoma” Proc. SPIE 9694, 96940K (2016); doi: 10.1117/12.2214463.
S. Lagnojita, J. T. Elliott, T. Hasan, B. W. Pogue, K. S. Samkoe, K. M. Tichauer, “Early photosensitizer uptake kinetics predict optimum drug-light interval for photodynamic therapy,” Proc. SPIE, 9308, 930811 (2015), doi: 10.1117/12.2077842.
E. V. Maytin, S. Anand, K. Rollakanti, “Clinical potential for vitamin D as a neoadjuvant for photodynamic therapy of nonmelanoma skin cancer,” Proc. SPIE, 9308, 93080H (2015), doi: 10.1117/12.2077234.
K. Rollakanti, S. Anand, E. V. Maytin, “Topical calcitrol prior to photodynamic therapy enhances treatment efficacy in non-melanoma skin cancer mouse models,” Proc. SPIE, 9308, 93080Q (2015), doi: 10.1117/12.2077296.
B. W. Pogue, S. Gioux, “Molecular-guided surgery,” Proc. SPIE, 9311, 931102-5, doi: 10.1117/12.2190063.
S. C. Davis, K. Sexton, M. S. Chapman, E. Maytin, T. Hasan, B. W. Pogue, “Pulsed light imaging for wide-field dosimetry of photodynamic therapy in the skin,” Proc. SPIE, 8931, 89310W (2014), doi: 10.1117/12.2040174.
A. V. DSouza, B. P. Flynn, J. R. Gunn, K. S. Samkoe, S. Anand, E. V. Maytin, T. Hasan, and B. W. Pogue, “ALA-PpIX variability quantitatively imaged in A431 epidermoid tumors using in vivo ultrasound fluorescence tomography and ex vivo assay,” Proc. SPIE, 8931, 893114 (2014), doi: 10.1117/12.2037800.
S. Anand, T. Hasan, and E. V. Maytin, “Mechanism of enhanced responses after combination photodynamic therapy (cPDT) in carcinoma cells involves C/EBP-mediated transcriptional upregulation of the coproporphyrinogen oxidase (CPO) gene,” Proc. SPIE, 856807-856807 (2013), doi: 10.1117/12.2004488.
B. P. Flynn, A. V. D’Souza, S. C. Kanick, E. Maytin, T. Hasan, and B. W. Pogue, “Subsurface PpIX imaging in vivo with ultrasound-guided tomographic spectroscopy: reconstruction vs. born-normalized data,” Proc. SPIE, 856809-856809 (2013), doi: 10.1117/12.2007502.
J. Gunn, K. Tichauer, K. Moodie, S. Kane, J. Hoopes, E. E. Stewart, J. Hadway, T.-Y. Lee, S. P. Pereira, and B. W. Pogue, “Pancreas tumor model in rabbit imaged by perfusion CT scans,” Proc. SPIE, 85681E-85681E (2013), doi: 10.1117/12.1518470.
M. Jermyn, S. C. Davis, H. Dehghani, M. Huggett, T. Hasan, S. P. Pereira, and B. W. Pogue, “Photodynamic therapy light dose analysis of a patient based upon arterial and venous contrast CT scan information,” Proc. SPIE, 85680Z-85680Z (2013), doi: 10.1117/12.2004003.
L. Mensah, S. Mallidi, I. Massodi, S. Anbil, Z. Mai, and T. Hasan, “Environmental effects on molecular biomarkers expression in pancreatic and brain cancer,” Proc. SPIE, 856803-856803 (2013), doi: 10.1117/12.2010697.
E. V. Maytin, S. Lohser, A. Tellez, L. Wene, R. Ishak, S. Anand, “Clinical studies of combined photodynamic therapy using 5-fluorouracil and methyl-aminolevulinate in patients at high risk for squamous cell carcinoma,” Proc. SPIE 8568, 85680N (2013); doi: 10.1117/12.2001882.
K. Rollakanti, S. Anand, E. V. Maytin,”In-vivo luminescence model for the study of tumor regression and regrowth following combination regimens with differentiation-promoting agents and photodynamic therapy,” Proc. SPIE 8568, 85680Y (2013); doi: 10.1117/12.2004637.
J. A. O’Hara, K. S. Samkoe, A. Chen, M. Isabelle, P. J. Hoopes, T. Hasan, and B. W. Pogue, “Histologic differences between orthotopic xenograft pancreas models affect Verteporfin uptake measured by fluorescence microscopy and spectroscopy,” Proc. SPIE, 821014-821014 (2012), doi: 10.1117/12.913049.
S. Torosean, B. Flynn, K. S. Samkoe, S. C. Davis, J. Gunn, J. Axelsson, and B. W. Pogue, “Double-excitation fluorescence spectral imaging: eliminating tissue auto-fluorescence from <i>in vivo</i> PPIX measurements,” Proc. SPIE, 82100Z-82100Z (2012), doi: 10.1117/12.909031.
S. Torosean, B. Flynn, K. S. Samkoe, J. Gunn, J. Axelsson, M. Doyley, and B. W. Pogue, “A high frequency ultrasound aided study of kinetics of drug delivery in tumor models,” Proc. SPIE, 83200Y-83200Y (2012), doi: 10.1117/12.911954.
M. Isabelle, W. Klubben, T. He, A. M. Laughney, A. Glaser, V. Krishnaswamy, P. J. Hoopes, T. Hasan, and B. W. Pogue, “Assessment of biophysical tumor response to PDT in pancreatic cancer using localized reflectance spectroscopy,” Proc. SPIE, 78860S-78860S (2011), doi: 10.1117/12.876147.
V. Krishnaswamy, A. M. Laughney, K. D. Paulsen, and B. W. Pogue, “A dark-field scanning spectroscopy platform for localized scatter and fluorescence imaging of tissue,” Proc. SPIE, 79070J-79070J (2011), doi: 10.1117/12.875462.
A. Paliwal, S. Torosean, J. Gruber, J. O’Hara, T. Hasan, B. Pogue, and E. V. Maytin, “In vivo validation of high frequency ultrasound-guided fluorescence tomography system to improve delivery of photodynamic therapy,” Proc. SPIE, 788610-788610 (2011), doi: 10.1117/12.875629.
E. V. Maytin, S. Anand, C. Wilson, K. Iyer, “”5-Fluorouracil as an enhancer of aminolevulinate-based photodynamic therapy for skin cancer: New use for a venerable agent?” Proc. SPIE 7886, 78860K (2011); doi: 10.1117/12.874188.
P. B. Garcia-Allende, O. M. Conde, V. Krishnaswamy, P. J. Hoopes, B. W. Pogue, J. Mirapeix, and J. M. Lopez-Higuera, “Automated ensemble segmentation of epithelial proliferation, necrosis, and fibrosis using scatter tumor imaging,” Proc. SPIE, 77151B-77151B (2010), doi: 10.1117/12.854559.
M. Isabelle, J. A. O’Hara, K. S. Samkoe, P. J. Hoopes, S. Mosse, S. Pereira, T. Hasan, and B. W. Pogue, “In vivo sampling of Verteporfin uptake in pancreas cancer xenograft models: comparison of surface, oral, and interstitial measurements,” Proc. SPIE, 755116-755116 (2010), doi: 10.1117/12.852779.
B. W. Pogue, S. Srinivasan, K. Samkoe, L. Z. Zheng, P. Rai, Z. Mai, S. Verma, and T. Hasan, “Analytic modeling of antibody versus nanocell delivery of photosensitizer,” Proc. SPIE, 755117-755117 (2010), doi: 10.1117/12.853925.
K. S. Samkoe, S. C. Davis, S. Srinivasan, M. E. Isabelle, J. O’Hara, T. Hasan, and B. W. Pogue, “EGF targeted fluorescence molecular tomography as a predictor of PDT outcomes in pancreas cancer models,” Proc. SPIE, 75510Q-75510Q (2010), doi: 10.1117/12.842934.
K. S. Samkoe, S. K. Hextrum, O. Pardesi, J. A. O’Hara, T. Hasan, and B. W. Pogue, “Specific binding of molecularly targeted agents to pancreas tumors and impact on observed optical contrast,” Proc. SPIE, 75680H-75680H (2010), doi: 10.1117/12.843009.
P. B. Garcia-Allende, V. Krishnaswamy, K. S. Samkoe, P. J. Hoopes, B. W. Pogue, O. M. Conde, and J. M. Lopez-Higuera, “Automated segmentation based upon remitted scatter spectra from pathologically distinct tumor regions,” Proc. SPIE, 718717-718717 (2009), doi: 10.1117/12.808322.
J. D. Gruber, V. Krishnaswamy, E. V. Maytin, T. Hasan, and B. W. Pogue, “System for fluorescence quantification of thin tissue layers guided by high frequency ultrasound,” Proc. SPIE, 71640N-71640N (2009), doi: 10.1117/12.809011.
J. O’Hara, K. S. Samkoe, A. Chen, P. J. Hoopes, I. Rizvi, T. Hasan, and B. W. Pogue, “Uptake of verteporfin by orthotopic xenograft pancreas models with different levels of aggression,” Proc. SPIE, 73805F-73805F (2009), doi: 10.1117/12.823214.
K. S. Samkoe, S. C. Davis, S. Srinivasan, J. A. O’Hara, T. Hasan, and B. W. Pogue, “A study of MRI-guided diffuse fluorescence molecular tomography for monitoring PDT effects in pancreas cancer,” Proc. SPIE, 73803M-73803M (2009), doi: 10.1117/12.823079.
C. B. Warren, S. Lohser, S. Chang, P. A. Bailin, E. V. Maytin, “In-vivo fluorescence dosimetry of aminolevulinate-based protoporphyrin IX (PpIX) accumulation in human nonmelanoma skin cancers and precancers,” Proc. SPIE 7380, 73801M (July 13, 2009); doi: 10.1117/12.822966.
S. Anand, G. Honari, A. Paliwal, T. Hasan, E. V. Maytin, “Enhancement of tumor responsiveness to aminolevulinate-photodynamic therapy (ALA-PDT) using differentiation-promoting agents in mouse models of skin carcinoma,” Proc. SPIE 7380, 73804B (2009); doi: 10.1117/12.822972.
E. V. Maytin, S. Anand, C. Baran, G. Honari, S. Lohser, A. Kyei, P. Bailin,B. W. Pogue, “Enhancement and optimization of PpIX-based photodynamic therapy of skin cancer: translational studies from bench to clinic,” Proc. SPIE 7164, 71640K (February 23, 2009); doi: 10.1117/12.808174.
S. L. Gibbs-Strauss, S. C. Davis, J. A. O’Hara, P. J. Hoopes, T. Hasan, and B. W. Pogue, “Noninvasive murine glioma detection improved following photobleaching of skin PpIX fluorescence,” Proc. SPIE, 68450D-68450D (2008), doi: 10.1117/12.762997.
V. Krishnaswamy, P. J. Hoopes, K. S. Samkoe, and B. W. Pogue, “A raster scanning reflectance imager for non-model based quantification of tissue scatter,” Proc. SPIE, 686402-686402 (2008), doi: 10.1117/12.761780.
T. Monahan, S. Jiang, and B. Pogue, “Fluorescence quantum yield of verteporfin is independent of oxygen,” Proc. SPIE, 684517-684517 (2008), doi: 10.1117/12.764244.
E. V. Maytin, S. Anand, N. Sato, B. Moore, J. Mack, C. Gasbarre, S. Keevey, B. Ortel, A. Sinha, and A. Khachemoune, “Nuclear transcription factors: a new approach to enhancing cellular responses to ALA-mediated photodynamic therapy”, Proc. SPIE 6139, 613909 (2006), doi: 10.1117/12.646880.
E. V. Maytin, S. Anand, N. Sato, J. Mack, and B. Ortel, “Harnessing cellular differentiation to improve ALA-based photodynamic therapy in an artificial skin model”, Proc. SPIE 5689, 318 (2005), doi: 10.1117/12.601940.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 

V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 

V. 
 V. 
 V.